Laurent Softic

Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)

Laurent Softic, Rozenn Brillet, François Berry et al. · Antimicrobial Agents and Chemotherapy · 2020 · 68 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly

Émilie Murigneux, Laurent Softic, C. Aubé et al. · Nature Communications · 2024 · 36 citations · Full text

Life Sciences, Biology, Molecular Biology +17

Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity

Quentin Nevers, Isaac Ruiz, Nazim Ahnou et al. · Antimicrobial Agents and Chemotherapy · 2018 · 15 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Proviral role of human respiratory epithelial cell‐derived small extracellular vesicles in SARS‐CoV‐2 infection

François Berry, Margot Morin‐Dewaele, Amene Majidipur et al. · Journal of Extracellular Vesicles · 2022 · 15 citations · Full text

Life Sciences, Cell Biology, Infectious Diseases +16

Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry

Margot Morin‐Dewaele, S. Bartier, François Berry et al. · Scientific Reports · 2022 · 11 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15